Smith J. Jefferson
Chief Research Officer
1 company
Insider Signal Score
69
StrongTrades Analyzed
6
12M Win Rate
100.0%
Avg 3M Return
-7.6%
Avg 12M Return
+35.9%
Smith J. Jefferson is a Chief Research Officer at PRECISION BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $905K based on current market prices.
Holdings by Company
DTILFeb 18, 2026
Current Shares121.9K
Value$904.7K
Net Activity-53,770
Bought: 0Sold: 53.8K
Transaction History
Showing 7 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | DTIL Precision Biosciences Inc | Chief Research Officer | Sale+OE | 4,925 | $3.84 | $18,912.00 | -3.9% | +79.2% | - | |
| Jan 21, 2026 | DTIL Precision Biosciences Inc | Chief Research Officer | Sale+OE | 10,200 | $4.03 | $41,106.00 | -8.5% | - | - | |
| Mar 4, 2025 | DTIL Precision Biosciences Inc | Chief Research Officer | Sale+OE | 154 | $4.91 | $756.14 | -0.2% | -1.0% | -6.2% | |
| Jan 22, 2025 | DTIL Precision Biosciences Inc | Chief Research Officer | Sale+OE | 10,287 | $4.79 | $49,274.73 | -10.5% | +7.0% | -14.5% | |
| Jun 10, 2024 | DTIL Precision Biosciences Inc | Chief Research Officer | Sale+OE | 50 | $11.79 | $589.50 | - | -15.8% | -57.4% | |
| May 2, 2024 | DTIL Precision Biosciences Inc | Chief Research Officer | Sale+OE | 154 | $10.32 | $1,589.28 | -0.2% | -12.1% | -47.0% | |
| Jan 23, 2024 | DTIL Precision Biosciences Inc | Chief Research Officer | Sale+OE | 28,000 | $0.37 | $10,360.00 | -1.4% | -11.6% | -54.6% |